Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma
Clinical trial NCT05879120 · WITHDRAWN
Trial details
- NCT number
- NCT05879120
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-30
- Primary completion
- 2024-10-02
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.